Understanding disease progression in complex, heterogeneous conditions like Huntington’s Disease is critical to designing successful clinical trials, but variability and small patient populations make this extremely challenging. Download our case study to learn how advanced data science and predictive modelling can uncover hidden patterns, improve patient stratification, and increase the probability of trial success.
What You’ll Learn
In this case study, you’ll discover how a biopharma organization:
Identified distinct patient subgroups using advanced clustering and machine learning techniques
Modeled disease progression across motor, cognitive, and behavioral domains
Uncovered key prognostic factors and biological drivers of disease progression
Applied predictive modelling to optimize trial design and patient selection
Increased probability of success for late-stage clinical trials
